U tubes and rare hepatobiliary complications

Brevetti, Gregory R.; Brevetti, Lucy S.; Giangobbe, Mitchell J.; Ukah, Ferdinand O.
March 1998
American Surgeon;Mar1998, Vol. 64 Issue 3, p270
Academic Journal
Discusses the complications associated with the use of U tubes in hepatobiliary disease. Purpose of using U tubes in hepatobiliary disease; Indications that requires the use of U tubes; Advantages of using U tubes.


Related Articles

  • ANTIOXIDANT PROPERTY OF PLANT AN INDICATION FOR HEPATOPROTECTIVE ACTIVITY. Panchal, Bhavna; Sharma, Ganesh N. // International Journal of Pharmacy & Technology;Oct2012, Vol. 4 Issue 3, p2286 

    Liver, the largest organ in the body is being evolved to maintain the body's internal milieu and also protect itself from the challenges it faces during its functioning. Since it is involved in the biochemical conversions of various endogenous and exogenously administered/ingested substances,...

  • Protective Effect of Hordeum vulgare Linn. on Acetaminophen-Induced Liver Damage. Shah, P. A.; Parmar, M. Y.; Thakkar, V. T.; Gandhi, T. R. // Journal of Young Pharmacists;2009, Vol. 1 Issue 4, p336 

    The objective of the present study has been to evaluate the hepatoprotective activity of methanolic extract of Hordeum vulgare Linn. (MEHV) seeds against acetaminophen-induced liver damage in rats. Acetaminopheninduced liver damage was produced by the treatment of acetaminophen (3g/kg/d, p.o.)...

  • Therapeutic Management of Hepatitis associated with Cholangitis in a Dog. Gupta, Amit Raj; Panigrahi, Padma Nibash; Das, Manisha // Intas Polivet;Jan-Jun2013, Vol. 14 Issue 1, p121 

    A eighteen months old German Shepherd dog was examined with complaint of recurrent inappetence, weakness and vomiting. Hematology showed leucocytosis with neutrophilia. Increase of ALT, ALP and GGT supported diagnosis of hepatobiliary disease. Abdominal ultrasound evaluation showed diffuse...

  • A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer. Kanai, Masashi; Yoshimura, Kenichi; Tsumura, Takehiko; Asada, Masanori; Suzuki, Chihiro; Niimi, Miyuki; Matsumoto, Shigemi; Nishimura, Takafumi; Nitta, Takashi; Yasuchika, Kentaro; Taura, Kojiro; Mori, Yukiko; Hamada, Akihiko; Inoue, Naoya; Tada, Shinsuke; Yanagihara, Kazuhiro; Yazumi, Shujiro; Osaki, Yukio; Chiba, Tsutomu; Ikai, Iwao // Cancer Chemotherapy & Pharmacology;Jun2011, Vol. 67 Issue 6, p1429 

    Purpose: We aimed to evaluate the efficacy and safety of gemcitabine/S-1 combination chemotherapy for the treatment of patients with advanced biliary tract cancer. Methods: Patients with histologically or cytologically confirmed unresectable or recurrent biliary tract cancer were eligible for...

  • Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections. Ober, Michael C.; Hoppe-Tichy, Torsten; Köninger, Jörg; Schunter, Oliver; Sonntag, Hans-Günther; Weigand, Markus A.; Encke, Jens; Gutt, Carsten; Swoboda, Stefanie // Journal of Antimicrobial Chemotherapy (JAC);Nov2009, Vol. 64 Issue 5, p1091 

    Objectives: Moxifloxacin, the newest fourth-generation fluoroquinolone, has a broad spectrum of antibacterial activity covering both Gram-positive and Gram-negative aerobic and anaerobic bacteria and is therefore very well suited for the treatment of biliary tract infections. The present study...

  • UPDATES IN ANTIBIOTIC THERAPY OF BILIARY TRACT INFECTIONS. Balahura, Cristian; Calistru, Petre Iacob; Constantinescu, Gabriel // Romanian Journal of Infectious Diseases;2015, Vol. 18 Issue 1, p34 

    Introduction. The management of biliary tract infections involves systemic antibiotherapy and a biliary drainage procedure. Current guidelines provide recommendations for empirical antimicrobial therapy in cholangitis but development of multi-drug resistant organisms can make many of these...

  • Primary biliary cirrhosis: Questions and promises. Lindor, Keith D. // Annals of Internal Medicine;05/01/97, Vol. 126 Issue 9, p733 

    Editorial. Discusses clinical issues raised by the study on the biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Use of methotrexate in patients who had been unresponsive to therapy; Appropriateness of various end points in future trials of...

  • Sustained biochemical and histologic remission of primary biliary cirrhosis in response to... Kaplan, Marshall M.; DeLellis, Ronald A. // Annals of Internal Medicine;05/01/97, Vol. 126 Issue 9, p682 

    Evaluates the response of primary biliary cirrhosis to low-dose oral methotrexate therapy. Positive response on some patients; Remission of primary biliary cirrhosis in response to methotrexate or in combination with colchicine or ursodiol; Progressive histologic improvement observed on the...

  • Double Plastic Stents for Distal Malignant Biliary Obstruction: Preliminary Evidence for a Novel Cost-Effective Alternative to Metal Stenting. Lawrence, Christopher; Romagnuolo, Joseph // American Journal of Gastroenterology;Feb2014, Vol. 109 Issue 2, p295 

    A letter to the editor offering information on the use of double plastic stents for distal malignant biliary obstruction is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics